Vaccins et traitements anti-Covid : pour faire primer le droit à la santé sur les intérêts commerciaux

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

Civil society organizations argue that intellectual property monopolies held by pharmaceutical companies have artificially restricted the supply of Covid-19 vaccines and inflated prices, leaving low-income countries dependent on donations via COVAX. They advocate for the adoption of a proposal by South Africa and India to temporarily lift patents on vaccines, treatments, and diagnostics to enable affordable local production, criticizing the European Union for proposing restrictive alternatives that protect commercial interests over public health.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • Pharmaceutical companies, including Pfizer/BioNTech, Moderna, and Johnson & Johnson, are accused of using Western government support to establish a hegemonic position and artificially limit the vaccine supply by restricting production units despite global demand.
  • Intellectual property monopolies have led to excessive pricing, making it nearly impossible for the poorest countries to purchase doses and leaving them dependent on the COVAX mechanism and donations from Western nations; consequently, fewer than one in five people in the poorest countries have received a vaccine dose.
  • Since October 2020, India and South Africa have proposed a temporary waiver of patents on Covid-19 vaccines, treatments, and diagnostic tools at the WTO to allow affordable production without the authorization of patent holders.
  • The European Union is criticized for introducing restrictive counter-proposals that exclude diagnostics and treatments and complicate the use of compulsory licenses and intellectual property waivers, which are already provided for in international law.

Cite the original document

APA
Bertrand, P., Spire, C., Pontual, S. B.-D., Rolland, C., Duflot, C., Devise, V., & Breysse, S. (2022). Vaccins et traitements anti-Covid : pour faire primer le droit à la santé sur les intérêts commerciaux. CCFD-Terre solidaire. https://ccfd-terresolidaire.org/vaccins-et-traitements-anti-covid-pour-faire-primer-le-droit-a-la-sante-sur-les-interets-commerciaux/
Chicago
Bertrand, Patrick, Camille Spire, Sylvie Bukhari-de Pontual, Carine Rolland, Cécile Duflot, Véronique Devise, and Serge Breysse. Vaccins et traitements anti-Covid : pour faire primer le droit à la santé sur les intérêts commerciaux. CCFD-Terre solidaire, 2022. https://ccfd-terresolidaire.org/vaccins-et-traitements-anti-covid-pour-faire-primer-le-droit-a-la-sante-sur-les-interets-commerciaux/.
Wikipedia
{{cite press release |last1=Bertrand |first1=Patrick |last2=Spire |first2=Camille |last3=Pontual |first3=Sylvie Bukhari-de |last4=Rolland |first4=Carine |last5=Duflot |first5=Cécile |last6=Devise |first6=Véronique |last7=Breysse |first7=Serge |title=Vaccins et traitements anti-Covid : pour faire primer le droit à la santé sur les intérêts commerciaux |publisher=CCFD-Terre solidaire |date=13 June 2022 |url=https://ccfd-terresolidaire.org/vaccins-et-traitements-anti-covid-pour-faire-primer-le-droit-a-la-sante-sur-les-interets-commerciaux/ |access-date=5 November 2026 |via=Climate Insights Directory (document ccfdts-000119)}}
BibTeX
@misc{bertrand2022vaccins, author = {Bertrand, Patrick and Spire, Camille and Pontual, Sylvie Bukhari-de and Rolland, Carine and Duflot, Cécile and Devise, Véronique and Breysse, Serge}, title = {{Vaccins et traitements anti-Covid : pour faire primer le droit à la santé sur les intérêts commerciaux}}, publisher = {CCFD-Terre solidaire}, year = {2022}, month = jun, url = {https://ccfd-terresolidaire.org/vaccins-et-traitements-anti-covid-pour-faire-primer-le-droit-a-la-sante-sur-les-interets-commerciaux/}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document ccfdts-000119} }

Full text

Collected · Record updated